CN Patent

CN1582169A — 基于热解法生产的二氧化硅的颗粒材料在药物组合物中的用途

Assigned to Evonik Operations GmbH · Expires 2005-02-16 · 21y expired

What this patent protects

本发明描述了基于热解法生产的二氧化硅的颗粒材料在药物组合物中的用途、该药物组合物本身，以及由该颗粒材料和至少一种选自药物活性成分和辅助物质的其它物质组成的吸附物，以及这种吸附物的生产。

USPTO Abstract

本发明描述了基于热解法生产的二氧化硅的颗粒材料在药物组合物中的用途、该药物组合物本身，以及由该颗粒材料和至少一种选自药物活性成分和辅助物质的其它物质组成的吸附物，以及这种吸附物的生产。

Drugs covered by this patent

Tybost (COBICISTAT) · Gilead Sciences

Patent Metadata

Patent number: CN1582169A
Jurisdiction: CN
Classification: —
Expires: 2005-02-16
Drug substance claim: No
Drug product claim: No
Assignee: Evonik Operations GmbH
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.